ARV-771 is a PROTAC targeting on pan-BET, containing a BRD4-binding moiety (JQ-1) and a VHL-binding moiety.
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | ARV-771 is a PROTAC targeting on pan-BET, containing a BRD4-binding moiety (JQ-1) and a VHL-binding moiety. Treatment with ARV-771 led to an efficient degradation of BRD2, 3 and 4 in CRPC cell lines (22Rv1, VCaP, and LnCaP95 cell lines) at concentration of 4, 11 and 34nM post 16h, and achieved a superior suppression of c-MYC on mRNA level at concentration of 10nM post 16h compared with BET small molecular inhibitor JQ-1 and OTX-015. Consistent with this effect on c-MYC by ARV-771, ARV-771 caused higher levels of CRPC cell growth inhibition and cell apoptosis compared with the treatment with JQ-1, OTX-015 and enzalutamide. Unlike BET inhibitors, the attenuation of AR signaling and AR levels could also be observed after ARV-771 treatment. Administration of ARV-771, s.c., once daily demonstrated efficiency in multiple tumor xenograft models of CRPC at various doses ranging in 3-30mg/kg. ARV-766 works as a negative control of ARV-771[1]. |
Dose | Mice: 10 mg/kg[1] (s.c.) |
Administration | s.c. |
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
1.01mL 0.20mL 0.10mL |
5.07mL 1.01mL 0.51mL |
10.14mL 2.03mL 1.01mL |
CAS号 | 1949837-12-0 |
分子式 | C49H60ClN9O7S2 |
分子量 | 986.64 |
SMILES Code | O=C([C@H]1N(C([C@H](C(C)(C)C)/N=C(O)/COCCCOCCNC(C[C@H]2C3=NN=C(C)N3C4=C(C(C)=C(C)S4)C(C5=CC=C(Cl)C=C5)=N2)=O)=O)C[C@H](O)C1)N[C@H](C6=CC=C(C7=C(C)N=CS7)C=C6)C |
MDL No. | MFCD30738017 |
别名 | |
运输 | 蓝冰 |
InChI Key | PQOGZKGXGLHDGS-QQRWPDCKSA-N |
Pubchem ID | 126619980 |
存储条件 |
In solvent -20°C:3-6个月-80°C:12个月 Pure form Sealed in dry, store in freezer, under -20°C |
溶解方案 |
请根据您的动物给药指南选择适当的溶解方案。 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|